Dr. Reza Bayat Mokhtari is a research-intensive biomedical scientist recognized for significant contributions to oncology and translational medicine, with a documented impact of 4,478 citations, an h-index of 20, and an i10-index of 30. The research portfolio focuses on molecular mechanisms of cancer progression, tumor microenvironment dynamics, and resistance to therapy, particularly in lung, breast, pancreatic, hepatic, and neuroendocrine malignancies. Core scientific contributions include studies on Hippo–YAP/TAZ signaling, Agrin-driven oncogenic processes, cancer stem cell regulation, hypoxia-associated pathways, and rational combination and repurposing strategies to improve immunotherapy outcomes. This body of peer-reviewed work bridges fundamental cancer biology with clinically relevant translational models, supporting biomarker development and precision oncology approaches. Overall, the scholarly output reflects sustained productivity, interdisciplinary scope, and measurable influence within the cancer research community.